Results per Page:
Bone marrow stroma (synde)can make a big difference to hematopoietic stem cells
From the Termini Lab, Translational Sciences and Therapeutics Division
Rebuilding a stem cell incubator: a fetal liver co-culture fosters the rarest blood cells
From the Hadland Lab, Translational Science and Therapeutics Division
Scientists see foam as starting point of a path to bedside gene therapy
Bioengineer Dr. Matthias Stephan developed a quick-foaming solution that he hopes could one day turn gene therapy into an outpatient procedure
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
Now you see them, now you don’t: Gene editing protects stem cells from CAR T therapy
From the Kiem lab, Translational Science and Therapeutics Division
Misbehaving monocytes drive graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Hematopoietic stem cell transplantation outcomes are worse among non-Hispanic Blacks and lower-income groups
From the Lee Lab, Clinical Research Division
Life after stem cell transplant: Finding ways to improve survivors’ transition back to work.
From Dr. Rachel Salit and colleagues, Clinical Research Division
Mellon, a single-cell analysis tool, identifies transitory cells and differentiation mechanisms
From the Setty Lab, Basic Sciences Division
A niche topic: understanding the development of hematopoietic stem cells
From the Hadland and Bernstein labs, Translational Science and Therapeutics Division
Bone marrow transplant increases risk of cardiovascular disease and developing insulin resistance.
From Drs. Tyler Ketterl, Scott Baker and colleagues, Clinical Research Division
From the bench to Hutch services: Refining gene-editing methods for HSPCs used in pre-clinical applications
From the Paddison lab, Human Biology Division
Fred Hutch pioneer Dr. Beverly Torok-Storb dies
Beloved mentor and bone marrow biologist created pathways for both blood cancer cures and marginalized students
The future of blood stem cell gene therapy is in vivo
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Investigating the emergence of hematopoietic stem cells in a mouse embryo
From the Hadland Lab, Clinical Research Division
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy
From the Kiem Lab, Clinical Research Division
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division